Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021
- PMID: 33200538
- DOI: 10.1002/jhbp.868
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021
Erratum in
-
Corrigendum.J Hepatobiliary Pancreat Sci. 2022 Apr;29(4):500. doi: 10.1002/jhbp.923. Epub 2021 Mar 15. J Hepatobiliary Pancreat Sci. 2022. PMID: 35481901 No abstract available.
Abstract
Background: Hepatectomy is standard treatment for colorectal liver metastases; however, it is unclear whether liver metastases from other primary cancers should be resected or not. The Japanese Society of Hepato-Biliary-Pancreatic Surgery therefore created clinical practice guidelines for the management of metastatic liver tumors.
Methods: Eight primary diseases were selected based on the number of hepatectomies performed for each malignancy per year. Clinical questions were structured in the population, intervention, comparison, and outcomes (PICO) format. Systematic reviews were performed, and the strength of recommendations and the level of quality of evidence for each clinical question were discussed and determined. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess evidence and make recommendations.
Results: The eight primary sites were grouped into five categories based on suggested indications for hepatectomy and consensus of the guidelines committee. Fourteen clinical questions were devised, covering five topics: (1) diagnosis, (2) operative treatment, (3) ablation therapy, (4) the eight primary diseases, and (5) systemic therapies. The grade of recommendation was strong for one clinical question and weak for the other 13 clinical questions. The quality of the evidence was moderate for two questions, low for 10, and very low for two. A flowchart was made to summarize the outcomes of the guidelines for the indications of hepatectomy and systemic therapy.
Conclusions: These guidelines were developed to provide useful information based on evidence in the published literature for the clinical management of liver metastases, and they could be helpful for conducting future clinical trials to provide higher-quality evidence.
Keywords: ablation therapy; disappearing liver metastases; hepatectomy; metastatic liver tumors; systemic therapy.
© 2020 Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Similar articles
-
Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.Health Technol Assess. 2020 Apr;24(21):1-38. doi: 10.3310/hta24210. Health Technol Assess. 2020. PMID: 32370822 Free PMC article. Clinical Trial.
-
Repeat hepatectomy for colorectal liver metastases.Ann Surg. 1997 Jan;225(1):51-60; discussion 60-2. doi: 10.1097/00000658-199701000-00006. Ann Surg. 1997. PMID: 8998120 Free PMC article.
-
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.J Hepatobiliary Pancreat Sci. 2012 Jan;19(1):72-84. doi: 10.1007/s00534-011-0460-z. J Hepatobiliary Pancreat Sci. 2012. PMID: 22020927
-
Electrocoagulation for liver metastases.Cochrane Database Syst Rev. 2021 Jan 28;1(1):CD009497. doi: 10.1002/14651858.CD009497.pub3. Cochrane Database Syst Rev. 2021. PMID: 33507555 Free PMC article.
-
[Treatment strategy for hepatic metastases of colorectal cancer].Nihon Geka Gakkai Zasshi. 2003 Oct;104(10):701-6. Nihon Geka Gakkai Zasshi. 2003. PMID: 14579755 Review. Japanese.
Cited by
-
Laparoscopic Surgery for a Patient With Multiple Liver Metastases of Unknown Origin Concomitant With Gallbladder Tumor.In Vivo. 2021 Sep-Oct;35(5):2963-2968. doi: 10.21873/invivo.12590. In Vivo. 2021. PMID: 34410995 Free PMC article.
-
Endoscopic ultrasound-guided tissue acquisition for focal liver lesions in patients with a history of multiple primary malignant neoplasms.DEN Open. 2024 Apr 30;5(1):e372. doi: 10.1002/deo2.372. eCollection 2025 Apr. DEN Open. 2024. PMID: 38694539 Free PMC article.
-
A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.Langenbecks Arch Surg. 2022 Jun;407(4):1345-1356. doi: 10.1007/s00423-022-02434-7. Epub 2022 Feb 25. Langenbecks Arch Surg. 2022. PMID: 35211831 Clinical Trial.
-
A Systematic Review of Disappearing Colorectal Liver Metastases: Resection or No Resection?J Clin Med. 2025 Feb 10;14(4):1147. doi: 10.3390/jcm14041147. J Clin Med. 2025. PMID: 40004679 Free PMC article. Review.
-
Implications of Liver-Directed Therapy for Postoperative Hepatic Metastasis from Esophageal Cancer.J Chest Surg. 2022 Oct 5;55(5):397-404. doi: 10.5090/jcs.22.031. Epub 2022 Aug 31. J Chest Surg. 2022. PMID: 36043230 Free PMC article.
References
REFERENCES
-
- Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386-422.
-
- Pavel M, O'Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172-85.
-
- Sano K, Yamamoto M, Mimura T, Endo I, Nakamori S, Konishi M, et al. Japanese Society of Hepato-Biliary-Pancreatic Surgery. Outcomes of 1,639 hepatectomies for non-colorectal non-neuroendocrine liver metastases: a multicenter analysis. J Hepatobiliary Pancreat Sci. 2018;25:465-75.
-
- Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE Working Group: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.
-
- Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719-25.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical